Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Deepak Jadon

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
Rheumatology (Oxford, England)|October 25, 2012
Exploring ankylosing spondylitis-associated ERAP1, IL23R and IL12B gene polymorphisms in subphenotypes of psoriatic arthritisDeepak Jadon, William Tillett, Dinny Wallis, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|August 26, 2023
The PROPER Study: A 48-Week, Pan-European, Real-World Study of Biosimilar SB5 Following Transition from Reference Adalimumab in Patients with Immune-Mediated Inflammatory DiseaseUlf Müller-Ladner, Axel Dignass, Karl Gaffney, et al.
The Journal of Rheumatology|August 1, 2023
Proceedings of the Collaborative Research Network Meeting at the GRAPPA 2022 Annual MeetingBeverly Cheok Kuan Ng, Deepak Jadon, Frank Behrens, et al.
Trials|March 5, 2021
Treating to target in psoriatic arthritis: assessing real-world outcomes and optimising therapeutic strategy for adults with psoriatic arthritis-study protocol for the MONITOR-PsA study, a trials within cohorts study designInes Rombach, William Tillett, Deepak Jadon, et al.
Rheumatology (Oxford, England)|February 23, 2024
Impact on patient outcomes of spondyloarthritis-inflammatory bowel disease multi-disciplinary meetingsSarah Sayers, Danielle Lam, Qutab Shah, et al.
BMJ Open|March 24, 2023
Protocol for the Psychosis Immune Mechanism Stratified Medicine (PIMS) trial: a randomised double-blind placebo-controlled trial of single-dose tocilizumab in patients with psychosisÉimear M Foley, Sian Lowri Griffiths, Alexander Murray, et al.
Rheumatology (Oxford, England)|May 31, 2022
The 2022 British Society for Rheumatology guideline for the treatment of psoriatic arthritis with biologic and targeted synthetic DMARDsLaura Tucker, Alexander Allen, David Chandler, et al.
Rheumatology (Oxford, England)|May 31, 2022
Executive summary: The 2022 British Society for Rheumatology guideline for the treatment of psoriatic arthritis with biologic and targeted synthetic DMARDsLaura Tucker, Alexander Allen, David Chandler, et al.
Rheumatology (Oxford, England)|October 24, 2020
Treatment of psoriatic arthritis with biologic and targeted synthetic DMARDs: British Society for Rheumatology guideline scopeWilliam Tillett, Alexander Allen, Laura Tucker, et al.
Scientific Reports|December 3, 2021
Application of information theoretic feature selection and machine learning methods for the development of genetic risk prediction modelsFarideh Jalali-Najafabadi, Michael Stadler, Nick Dand, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Rheumatology (Oxford, England)|October 25, 2012
Exploring ankylosing spondylitis-associated ERAP1, IL23R and IL12B gene polymorphisms in subphenotypes of psoriatic arthritisDeepak Jadon, William Tillett, Dinny Wallis, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|August 26, 2023
The PROPER Study: A 48-Week, Pan-European, Real-World Study of Biosimilar SB5 Following Transition from Reference Adalimumab in Patients with Immune-Mediated Inflammatory DiseaseUlf Müller-Ladner, Axel Dignass, Karl Gaffney, et al.
The Journal of Rheumatology|August 1, 2023
Proceedings of the Collaborative Research Network Meeting at the GRAPPA 2022 Annual MeetingBeverly Cheok Kuan Ng, Deepak Jadon, Frank Behrens, et al.
Trials|March 5, 2021
Treating to target in psoriatic arthritis: assessing real-world outcomes and optimising therapeutic strategy for adults with psoriatic arthritis-study protocol for the MONITOR-PsA study, a trials within cohorts study designInes Rombach, William Tillett, Deepak Jadon, et al.
Rheumatology (Oxford, England)|February 23, 2024
Impact on patient outcomes of spondyloarthritis-inflammatory bowel disease multi-disciplinary meetingsSarah Sayers, Danielle Lam, Qutab Shah, et al.
BMJ Open|March 24, 2023
Protocol for the Psychosis Immune Mechanism Stratified Medicine (PIMS) trial: a randomised double-blind placebo-controlled trial of single-dose tocilizumab in patients with psychosisÉimear M Foley, Sian Lowri Griffiths, Alexander Murray, et al.
Rheumatology (Oxford, England)|May 31, 2022
The 2022 British Society for Rheumatology guideline for the treatment of psoriatic arthritis with biologic and targeted synthetic DMARDsLaura Tucker, Alexander Allen, David Chandler, et al.
Rheumatology (Oxford, England)|May 31, 2022
Executive summary: The 2022 British Society for Rheumatology guideline for the treatment of psoriatic arthritis with biologic and targeted synthetic DMARDsLaura Tucker, Alexander Allen, David Chandler, et al.
Rheumatology (Oxford, England)|October 24, 2020
Treatment of psoriatic arthritis with biologic and targeted synthetic DMARDs: British Society for Rheumatology guideline scopeWilliam Tillett, Alexander Allen, Laura Tucker, et al.
Scientific Reports|December 3, 2021
Application of information theoretic feature selection and machine learning methods for the development of genetic risk prediction modelsFarideh Jalali-Najafabadi, Michael Stadler, Nick Dand, et al.
Pageof 3